Falsified Medical Product Alert N°1/2025
OXYCONTIN 80mg (oxycodone hydrochloride) tablets: falsified product alert
WHO issued this alert on one falsified batch of OXYCONTIN 80mg detected in the unregulated market in Switzerland and reported to WHO in February 2025 by MUNDIPHARMA. Testing by the Drug Information Centre of the City of Zurich found the tablets contained no oxycodone but a synthetic opioid likely to be a nitazene compound. On falsified packs the batch and expiry date are printed on the front of the blister strip.1
- Issued
- 12 March 2025
- Issued by
- World Health Organization
- Name stated on packaging
- The falsified product imitates OXYCONTIN 80mg manufactured and marketed by MUNDIPHARMA in the Polish market.
- Genuine manufacturer's statement
- WHO said MUNDIPHARMA confirmed the product is falsified and was not produced by its company.
- Countries where detected
- Switzerland
Batches named in the alert
One batch, listed in the annex to the alert
Advice as stated
Do not use these products. Seek immediate medical help or contact a poison control centre after exposure. Health professionals should consider nitazene poisoning in suspected overdoses.
Names printed on falsified products are not evidence that the named company made them. Where WHO or a regulator reports the genuine manufacturer's statement, it is shown.
Sources
- World Health Organization, Medical Product Alert N°1/2025: Falsified (contaminated) OXYCONTIN 80mg (12 March 2025)